Search research articles
Contact Us
Filters
Showing results (211-220 of 224) with videos related to
Page
of 23
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 1999
Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients
J E Gershenwald, W Thompson, P F Mansfield, et al.
Journal of the American College of Surgeons
|
July 11, 1998
Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: the final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial
M K Wallack, M Sivanandham, C M Balch, et al.
Annals of Surgical Oncology
|
January 1, 1994
What is a surgical oncologist?
C M Balch, K I Bland, M F Brennan, et al.
Annals of Surgical Oncology
|
April 13, 2000
Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial
C M Balch, S Soong, M I Ross, et al.
Annals of Surgery
|
August 1, 1997
Increased survival of patients treated with a vaccinia melanoma oncolysate vaccine: second interim analysis of data from a phase III, multi-institutional trial
M K Wallack, M Sivanandham, K Ditaranto, et al.
Annals of Surgical Oncology
|
March 22, 2001
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas
C M Balch, S J Soong, T Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
Prognostic factors for survival of patients treated systemically for disseminated melanoma
O Eton, S S Legha, T E Moon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1997
Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system
A C Buzaid, M I Ross, C M Balch, et al.
Annals of Surgery
|
September 1, 1996
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger
C M Balch, S J Soong, A A Bartolucci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma
O Eton, D D Kharkevitch, M A Gianan, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 224) with videos related to
Sort By:
Page
of 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 1999
Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients
J E Gershenwald, W Thompson, P F Mansfield, et al.
Journal of the American College of Surgeons
|
July 11, 1998
Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: the final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial
M K Wallack, M Sivanandham, C M Balch, et al.
Annals of Surgical Oncology
|
January 1, 1994
What is a surgical oncologist?
C M Balch, K I Bland, M F Brennan, et al.
Annals of Surgical Oncology
|
April 13, 2000
Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial
C M Balch, S Soong, M I Ross, et al.
Annals of Surgery
|
August 1, 1997
Increased survival of patients treated with a vaccinia melanoma oncolysate vaccine: second interim analysis of data from a phase III, multi-institutional trial
M K Wallack, M Sivanandham, K Ditaranto, et al.
Annals of Surgical Oncology
|
March 22, 2001
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas
C M Balch, S J Soong, T Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
Prognostic factors for survival of patients treated systemically for disseminated melanoma
O Eton, S S Legha, T E Moon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1997
Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system
A C Buzaid, M I Ross, C M Balch, et al.
Annals of Surgery
|
September 1, 1996
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger
C M Balch, S J Soong, A A Bartolucci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma
O Eton, D D Kharkevitch, M A Gianan, et al.
Page
of 23